Agilent Technologies Inc vs PAGSEG Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while PAGSEG Inc trades at $8.91 (market cap $2.54B). The key difference: Agilent Technologies Inc is far larger — about 16.5× PAGSEG Inc's market cap, and PAGSEG Inc pays the higher dividend (11.45%). Which is the better fit depends on your goals.
| A | PAGS | |
|---|---|---|
Market Cap | $42.00B | $2.54B |
Sector | Health | Technology |
52-Week High | $157.20 | $12.00 |
52-Week Low | $110.24 | $8.38 |
Enterprise Value | $43.55B | $10.31B |
Dividend Yield | 0.69% | 11.45% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
PAGS trades at $9.14, down 2.35% on the day, with a bearish technical signal from moving averages but oversold RSI conditions. The stock shows strong fundamentals with a P/E of 6.31, net income margin of 10.4%, and positive cash flow. Recent earnings have been mixed, with a miss in Q1 2026 but a beat in Q4 2025, while analyst sentiment remains largely positive.
The outlook for PAGS is cautiously optimistic, supported by deep value metrics and a consensus price target of $11.45, implying significant upside. Risks include competitive pressures in financial services and sensitivity to Brazilian interest rates, but robust profitability and aggressive capital returns provide a buffer against near-term volatility.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →